Medy-Tox (086900.KQ) Earnings Analysis
Medy-Tox (086900.KQ) next reports earnings on 2026-08-07, consensus EPS 729.09 KRW. Last quarter (2026-03-12) it missed with EPS -390.23 KRW vs 814.27 KRW est (-147.9%). It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E 22.35.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 086900.KQ next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | 729.09 KRW |
| Revenue estimate | 65.40B |
086900.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-12 | -390.23 KRW | 814.27 KRW | -147.9% | Miss |
| 2025-11-10 | 1,093.07 KRW | n/a | n/a | n/a |
| 2025-05-12 | 542.15 KRW | n/a | n/a | n/a |
| 2025-03-13 | 451.35 KRW | n/a | n/a | n/a |
| 2024-11-11 | 566 KRW | n/a | n/a | n/a |
| 2024-08-09 | 1,695 KRW | 2,058 KRW | -17.6% | Miss |
Beat rate: 0/2 (0%) over reported quarters with consensus data.
086900.KQ valuation and analyst view
| Trailing P/E | 22.35 |
|---|---|
| Trailing EPS | 2,790.84 KRW |
| Price / book | 1.41 |
| Dividend yield | 1.68% |
| Market cap | 445.15B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Medy-Tox (086900.KQ)'s next earnings date?
Medy-Tox is next scheduled to report on 2026-08-07, with a consensus EPS estimate of 729.09 KRW and revenue estimate of 65.40B.
Did 086900.KQ beat earnings last quarter?
In its 2026-03-12 report, 086900.KQ posted EPS of -390.23 KRW versus a 814.27 KRW estimate — a miss of 147.9%.
What is 086900.KQ's earnings track record?
Over the last 2 reported quarters with consensus data, 086900.KQ beat estimates 0 times (0%).
What is 086900.KQ's current P/E ratio and EPS?
086900.KQ trades at a trailing P/E of 22.35 on trailing EPS of 2790.8416485900216 KRW.
What do analysts rate 086900.KQ?
086900.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.